WeVote
Log In

Bill

Bill

S 8334

Relates to insurance reimbursement for vaccination for severe acute respiratory syndrome coronavirus 2

2025 Regular Session Introduced by Andrew Gounardes

Bill S 8334 mandates insurance coverage for all SARS-CoV-2 vaccinations, eliminating out-of-pocket costs to boost public health and vaccination rates.

REFERRED TO INSURANCE
0
WeVote Research Nonpartisan
Bill Summary · S 8334

Summary of Bill S 8334

Bill Information

  • Bill Number: S 8334
  • Title: Relates to insurance reimbursement for vaccination for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Status: Referred to Insurance
  • Introduced: June 03, 2025
  • Classification: Bill

Purpose and Intent

Bill S 8334 aims to ensure that insurance providers are required to reimburse costs associated with vaccinations for SARS-CoV-2, the virus responsible for COVID-19. The intent of this legislation is to promote public health by facilitating access to vaccinations, thereby encouraging higher vaccination rates among the population.

Key Provisions

  • Insurance Reimbursement: The bill mandates that health insurance plans cover the full cost of vaccinations for SARS-CoV-2 without imposing any out-of-pocket expenses on the insured individuals.
  • Scope of Coverage: The legislation specifies that the reimbursement applies to all approved vaccines for SARS-CoV-2, including any future vaccines that may be developed and authorized for use.
  • Implementation Timeline: The bill outlines a timeline for insurance companies to comply with the new reimbursement requirements, ensuring that coverage is available promptly following the bill's enactment.

Affected Parties

  • Individuals: The primary beneficiaries of this bill are individuals seeking vaccination against SARS-CoV-2, as it removes financial barriers to accessing vaccines.
  • Insurance Providers: Health insurance companies will be required to adjust their policies and reimbursement processes to align with the new mandates set forth in the bill.
  • Healthcare Providers: Clinics and hospitals administering the vaccines will also be affected, as they will need to ensure compliance with the reimbursement procedures established by insurance companies.

Legislative Actions

  • June 03, 2025: The bill was introduced and referred to the Rules Committee.
  • June 09, 2025: The bill was ordered to third reading, passed in the Senate, and subsequently delivered to the Assembly, where it was referred to the Insurance Committee.

Related Bills

  • A 8824: This is the companion bill in the Assembly that addresses similar issues regarding insurance reimbursement for SARS-CoV-2 vaccinations.

Conclusion

Bill S 8334 represents a significant step towards enhancing public health measures by ensuring that financial barriers do not impede access to COVID-19 vaccinations. By mandating insurance reimbursement for these vaccines, the bill seeks to increase vaccination rates and contribute to the overall effort to control the spread of SARS-CoV-2.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.